Home › Upcoming votes › Modular Medical, Inc.
This meeting took place on October 23, 2026. Modular Medical, Inc. reported the official results on Form 8-K, filed October 28, 2026 (read it on EDGAR); they are listed below.
The deadline as the proxy statement states it: “voting instructions and for electronic delivery of information up until 11:59 p.m. Eastern Time on October 22, 2026”. Shares held through a bank, a broker or a company plan can have a different deadline; the voting instruction form says.
Read the proxy statement on EDGAR
Ballot read from the proxy statement and checked. As listed in Modular Medical, Inc.’s proxy statement, with the board’s recommendation on each item.
| # | Item | Proposed by | Board recommends | Last year (same kind of item) |
|---|---|---|---|---|
| 1 | ELECTION OF DIRECTORS TO SERVE UNTIL THE NEXT ANNUAL MEETING OF SHAREHOLDERS AND UNTIL THEIR RESPECTIVE SUCCESSORS SHALL HAVE BEEN DULY ELECTED AND QUALIFIED Director election |
Board | For | 8 nominees; support 89% to 99.6% |
| 2 | TO APPROVE AN AMENDMENT TO THE 2017 PLAN | Board | For | — |
| 3 | RATIFICATION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING MARCH 31, 2027 Auditor |
Board | For | 99.8% support |
From Modular Medical, Inc.’s Form 8-K, filed January 23, 2026, for the meeting held January 23, 2026 (read it on EDGAR). Support is the share of votes cast that were FOR: abstentions and broker non-votes are left out.
| Item | Support (of votes cast) | Reported outcome |
|---|---|---|
| Elect Director: Duane DeSisto | 99% | Elected |
| Elect Director: Paul DiPerna | 89% | Elected |
| Elect Director: Steven Felsher | 95% | Elected |
| Elect Director: Morgan Frank | 94% | Elected |
| Elect Director: Jeffrey Goldberg | 99.6% | Elected |
| Elect Director: Philip Sheibley | 95% | Elected |
| Elect Director: Carmen Volkart | 99.2% | Elected |
| Elect Director: Ellen O'Connor Vos | 90% | Elected |
| The foregoing proposal was approved. | 90% | Approved |
| 4. Amendment of the Amended and Restated 2017 Equity Incentive Plan, as amended, to increase the number of shares currently reserved for iss | 86% | Approved |
| 5. Approval, on a non-binding advisory basis, of the compensation of the named executive officers | 92% | Approved |
| 6. Ratification of the audit committee's appointment of Farber Hass Hurley LLP as independent registered public accounting firm for the fisc | 99.8% | Approved |
| Item | Support (of votes cast) | Reported outcome |
|---|---|---|
| Elect Director: James E. Besser | 82% | Elected |
| Elect Director: Paul DiPerna | 84% | Elected |
| Elect Director: Duane DeSisto | 99.1% | Elected |
| Elect Director: Steven Felsher | 85% | Elected |
| Elect Director: Philip Sheibley | 85% | Elected |
| Elect Director: Ellen O'Connor Vos | 66% | Elected |
| 2. Amendment of the Amended and Restated 2017 Equity Incentive Plan (as amended from time to time) to increase the number of shares availabl | 74% | Approved |
| 3. Ratification of the audit committee's appointment of Farber Hass Hurley LLP as independent registered public accounting firm for the fisc | 99.7% | Approved |
The meeting facts and ballot come from the SEC proxy filings listed above. Ballots are read from the proxy statement and checked against the filing’s own text; when that check does not pass, the page shows “see the proxy statement” instead of a ballot. Last year’s figures are the company’s official Form 8-K results and the managers’ Form N-PX reports. Nothing on this page predicts how any shareholder will vote, and it is not investment advice. How this works.